Real-World outcomes with sacituzumab govitecan among breast cancer patients with central nervous system metastases
Abstract Central nervous system (CNS) metastases are associated with poor prognosis in patients with metastatic breast cancer (MBC). In this retrospective study, we investigated the activity of sacituzumab govitecan (SG) in 33 patients with HER2-negative MBC and CNS metastases, including active, sta...
Збережено в:
| Автори: | , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Nature Portfolio
2025-03-01
|
| Серія: | npj Breast Cancer |
| Онлайн доступ: | https://doi.org/10.1038/s41523-025-00736-9 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|